Orthopedic Extension Devices Market, By Product Type (Hip Surgery, Knee Surgery, Spine Surgery, Arm Surgery, and Others), By End User (Hospitals, Ambulatory Surgical Centers, Speciality Clinics), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In : Jun 2023

Code : CMI3780

Pages :175

Formats :

Excel and PDF

Industry : Medical Devices

Market News

Global Orthopedic Extension Devices Market : Key Developments

On February 17, 2023, Curiteva, Inc., a spinal implant technology company based in the U.S, got U.S. FDA clearance for its Inspire 3D Porous PEEK Cervical Interbody System Technology. The implant technology exhibits good mechanical strength and helps to achieve a modulus of elasticity closely matching human cancellous bone.

On April 7, 2023, Ukraine’s civilian Emergency Medical Clinical Hospital collaborated with T&R Biofab, a U.S-based 3-D bioprinting specialist, to replicate special tissue microenvironments that would provided the ideal mileu for a skull implant that would be strong enough and that would enable the bone to grow back onto and into it.

On January 30, 2023, Additive Surgical, an Australia-based medical device manufacturer of 3D printed titanium, spine implant technology, launched a range of expandable interbody devices. The whole implant has a microporosity of 6-10 microns (surface texture) that creates a favorable environment for bony on-growth.

On January 27, 2023, Croom Medical, an outsourcing partner for the design and manufacture of orthopedic implants, introduced a 3D printed Sacroiliac Joint Fixation. The device provides biomechanical stability, support, and range of motions for patients suffering from SI joint dysfunction.

Global Orthopedic Extension Devices Market: Key Trends

On January 25, 2023, Trabtech, a Turkey-based technology company that provides training and consulting services in modeling and design, additive manufacturing as well as 3D anatomical modeling and design and customized solutions/services, invested US$ 1.3 million to fund the development of advanced 3D printed implant applications. With this funding, Trabtech will be able to complete the regulatory process for its new products, relocate its headquarters to Germany to enter the EU market and prepare for U.S. FDA approval, while commercializing its first mass-produced product, the TrabCup hip prosthesis.

In December 2021, Health Canada- the official drug regulatory authority of Canada, authorized the use of 3D printed mandibular implant to enable surgeons and medical professionals to use the Specific mandibular plate, along with surgical cutting and drilling guides, to treat patients. The implant reduces operation time and patient recovery time.